par de Castro, Gilberto; Awada, Ahmad Liste de publications
Référence Current opinion in oncology, 18, 4, (page 307-315)
Publication Publié, 2006-07
Article révisé par les pairs
Titre :
  • Side effects of anti-cancer molecular-targeted therapies (not monoclonal antibodies).
Auteur : de Castro, Gilberto ; Awada, Ahmad
Informations sur la publication : Current opinion in oncology, 18, 4, (page 307-315)
Statut de publication : Publié, 2006-07
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Anti-angiogenic agents
Bortezomib
Farnesyltransferase inhibitors
Lenalidomide
Molecular-targeted therapies
Tyrosine-kinase inhibitors
Mots-clés MeSH : Antineoplastic Agents -- adverse effects
Boronic Acids -- adverse effects
Drug Design
Farnesyltranstransferase -- antagonists & inhibitors
Humans
Immunologic Factors -- adverse effects
Neoplasms -- therapy
Protease Inhibitors -- pharmacology
Proteasome Endopeptidase Complex -- metabolism
Protein-Tyrosine Kinases -- antagonists & inhibitors
Pyrazines -- adverse effects
Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
Thalidomide -- adverse effects
Thalidomide -- analogs & derivatives
Note : Journal Article
Review
Langue :
  • Anglais
Identificateurs : urn:issn:1040-8746 
info:doi/10.1097/01.cco.0000228733.55132.ea
info:pii/00001622-200607000-00002
info:pmid/16721122